HIGH TIDE INC (HITI) Stock Fundamental Analysis

NASDAQ:HITI • CA42981E4013

2.575 USD
+0.01 (+0.19%)
Last: Feb 26, 2026, 02:13 PM
Fundamental Rating

4

HITI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. HITI has a medium profitability rating, but doesn't score so well on its financial health evaluation. HITI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • HITI had negative earnings in the past year.
  • In the past year HITI had a positive cash flow from operations.
  • HITI had negative earnings in each of the past 5 years.
  • Of the past 5 years HITI 4 years had a positive operating cash flow.
HITI Yearly Net Income VS EBIT VS OCF VS FCFHITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • HITI's Return On Assets of -14.54% is fine compared to the rest of the industry. HITI outperforms 64.06% of its industry peers.
  • With a Return On Equity value of -57.92%, HITI perfoms like the industry average, outperforming 48.44% of the companies in the same industry.
  • The Return On Invested Capital of HITI (5.17%) is better than 83.33% of its industry peers.
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROIC 5.17%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
HITI Yearly ROA, ROE, ROICHITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • The Operating Margin of HITI (2.74%) is better than 78.65% of its industry peers.
  • In the last couple of years the Operating Margin of HITI has grown nicely.
  • The Gross Margin of HITI (25.99%) is comparable to the rest of the industry.
  • HITI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.74%
PM (TTM) N/A
GM 25.99%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
HITI Yearly Profit, Operating, Gross MarginsHITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HITI is destroying value.
  • Compared to 1 year ago, HITI has more shares outstanding
  • The number of shares outstanding for HITI has been increased compared to 5 years ago.
  • The debt/assets ratio for HITI is higher compared to a year ago.
HITI Yearly Shares OutstandingHITI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
HITI Yearly Total Debt VS Total AssetsHITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • HITI has an Altman-Z score of 1.67. This is a bad value and indicates that HITI is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of HITI (1.67) is better than 60.94% of its industry peers.
  • The Debt to FCF ratio of HITI is 8.31, which is on the high side as it means it would take HITI, 8.31 years of fcf income to pay off all of its debts.
  • HITI has a Debt to FCF ratio of 8.31. This is amongst the best in the industry. HITI outperforms 81.77% of its industry peers.
  • HITI has a Debt/Equity ratio of 0.94. This is a neutral value indicating HITI is somewhat dependend on debt financing.
  • HITI has a Debt to Equity ratio of 0.94. This is in the lower half of the industry: HITI underperforms 72.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Altman-Z 1.67
ROIC/WACC0.57
WACC9.13%
HITI Yearly LT Debt VS Equity VS FCFHITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • HITI has a Current Ratio of 1.37. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.37, HITI is doing worse than 73.44% of the companies in the same industry.
  • HITI has a Quick Ratio of 1.37. This is a bad value and indicates that HITI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HITI has a worse Quick ratio (0.70) than 85.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.7
HITI Yearly Current Assets VS Current LiabilitesHITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

  • The earnings per share for HITI have decreased strongly by -884.13% in the last year.
  • Looking at the last year, HITI shows a quite strong growth in Revenue. The Revenue has grown by 13.72% in the last year.
  • Measured over the past years, HITI shows a very strong growth in Revenue. The Revenue has been growing by 48.14% on average per year.
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%

3.2 Future

  • HITI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.45% yearly.
  • The Revenue is expected to grow by 13.03% on average over the next years. This is quite good.
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue Next Year26.45%
Revenue Next 2Y21.62%
Revenue Next 3Y16.73%
Revenue Next 5Y13.03%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HITI Yearly Revenue VS EstimatesHITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
HITI Yearly EPS VS EstimatesHITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

  • HITI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 26.44, which means the current valuation is very expensive for HITI.
  • Based on the Price/Forward Earnings ratio, HITI is valued a bit cheaper than the industry average as 73.96% of the companies are valued more expensively.
  • HITI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.03.
Industry RankSector Rank
PE N/A
Fwd PE 26.44
HITI Price Earnings VS Forward Price EarningsHITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HITI is valued cheaper than 90.10% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HITI is valued cheaply inside the industry as 84.38% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.45
EV/EBITDA 9.14
HITI Per share dataHITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • HITI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HITI's earnings are expected to grow with 46.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.32%
EPS Next 3Y46.8%

0

5. Dividend

5.1 Amount

  • HITI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HIGH TIDE INC

NASDAQ:HITI (2/26/2026, 2:13:45 PM)

2.575

+0.01 (+0.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)03-13
Inst Owners13.66%
Inst Owner Change-0.2%
Ins Owners8.85%
Ins Owner ChangeN/A
Market Cap226.45M
Revenue(TTM)593.99M
Net Income(TTM)-50.75M
Analysts80
Price Target5.34 (107.38%)
Short Float %0.41%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.04%
Min Revenue beat(2)0.98%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.13%
Revenue beat(12)9
Avg Revenue beat(12)0.97%
Revenue beat(16)13
Avg Revenue beat(16)7.41%
PT rev (1m)0.99%
PT rev (3m)1.63%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-2.49%
Revenue NY rev (3m)-2.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.44
P/S 0.52
P/FCF 23.45
P/OCF 12.99
P/B 3.54
P/tB N/A
EV/EBITDA 9.14
EPS(TTM)-0.45
EYN/A
EPS(NY)0.1
Fwd EY3.78%
FCF(TTM)0.11
FCFY4.26%
OCF(TTM)0.2
OCFY7.7%
SpS4.93
BVpS0.73
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROCE 6.54%
ROIC 5.17%
ROICexc 6.4%
ROICexgc 17.98%
OM 2.74%
PM (TTM) N/A
GM 25.99%
FCFM 2.23%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.85%
ROICexc growth 3YN/A
ROICexc growth 5Y9.97%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
F-Score2
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Debt/EBITDA 2.03
Cap/Depr 43.8%
Cap/Sales 1.79%
Interest Coverage 2.21
Cash Conversion 58.77%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.7
Altman-Z 1.67
F-Score2
WACC9.13%
ROIC/WACC0.57
Cap/Depr(3y)33.59%
Cap/Depr(5y)35.25%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%
Revenue Next Year26.45%
Revenue Next 2Y21.62%
Revenue Next 3Y16.73%
Revenue Next 5Y13.03%
EBIT growth 1Y6.44%
EBIT growth 3YN/A
EBIT growth 5Y64.03%
EBIT Next Year707.98%
EBIT Next 3Y142.78%
EBIT Next 5Y76.98%
FCF growth 1Y-48.76%
FCF growth 3YN/A
FCF growth 5Y16.8%
OCF growth 1Y-32.86%
OCF growth 3Y74.46%
OCF growth 5Y21.95%

HIGH TIDE INC / HITI FAQ

What is the fundamental rating for HITI stock?

ChartMill assigns a fundamental rating of 4 / 10 to HITI.


What is the valuation status for HITI stock?

ChartMill assigns a valuation rating of 5 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.


Can you provide the profitability details for HIGH TIDE INC?

HIGH TIDE INC (HITI) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for HITI stock?

The Earnings per Share (EPS) of HIGH TIDE INC (HITI) is expected to grow by 121.5% in the next year.